In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Telemonitoring: a bridge to personalised medicine

ESC Congress 2009 - Arrhythmias: time for action

Arrhythmias


Barcelona, Spain, 1 September: An increasing number of heart failure patients are treated with a number of complex devices, i.e. cardiac resynchronization therapy (CRT).  Recently completed and ongoing clinical trials such as MADIT-CRT and EchoCRT provide evidence of a growing number of CRT patients, in need of individualised treatment. Rising demand for implantable cardiac devices and the simultaneous need for increased efficiency as well as enhanced patient comfort and safety significantly increase the need for remote monitoring technology. 

Despite the wide availability of telemonitoring systems in many European countries, currently only around 1% of patients with implantable cardiac devices in Europe are being monitored remotely. The majority are still being followed up by conventional in-office follow-up schemes. By the end of 2008, approximately 23.000 European patients were being monitored remotely.

Telemonitoring enables the safe reduction of traditional face to face follow-ups, thereby reducing physicians’ workload by focusing on individual patients who need clinical attention. Telemonitoring studies such as TRUST, REFORM and ISMOS have shown that the number of regular in-office medical check-ups can be reduced by about 50% without risking patient’s safety. It also enables early detection of silent, asymptomatic arrhythmias allowing for earlier intervention compared to conventional follow-ups, since all patient data are updated on a daily basis. This facilitates a need-based and individualised patient aftercare, complying with the current HRS/EHRA recommendations and giving patients freedom, mobility, and a sense of relief, knowing that their heart is under continuous surveillance.

- Ends -

Notes to editor

This press release accompanies both a presentation and an ESC press conference given at the ESC Congress 2009. Written by the investigator himself/herself, this press release does not necessarily reflect the opinion of the European Society of Cardiology.